100 related articles for article (PubMed ID: 22468818)
1. Epigenetic and genetic alterations-based molecular classification of head and neck cancer.
Feng Z; Xu Q; Chen W
Expert Rev Mol Diagn; 2012 Apr; 12(3):279-90. PubMed ID: 22468818
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
Le QT; Giaccia AJ
Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
[TBL] [Abstract][Full Text] [Related]
4. Biological agents in head and neck cancer.
Bossi P; Locati LD; Licitra L
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1643-50. PubMed ID: 18020930
[TBL] [Abstract][Full Text] [Related]
5. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
7. Role of molecular markers in the management of head and neck cancers.
Ferreira MB; De Souza JA; Cohen EE
Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
[TBL] [Abstract][Full Text] [Related]
8. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
Azad AK; Bairati I; Samson E; Cheng D; Mirshams M; Qiu X; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
Clin Cancer Res; 2012 Jan; 18(1):196-206. PubMed ID: 22076708
[TBL] [Abstract][Full Text] [Related]
9. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors in squamous cell carcinoma of the head and neck].
Horiuchi M; Tamura Y
Gan To Kagaku Ryoho; 1996 Jun; 23(7):949-56. PubMed ID: 8678550
[TBL] [Abstract][Full Text] [Related]
11. Molecular approaches to the staging of head and neck carcinomas (review).
Gasparotto D; Maestro R
Int J Oncol; 2007 Jul; 31(1):175-80. PubMed ID: 17549419
[TBL] [Abstract][Full Text] [Related]
12. Translational genomics and head and neck cancer: toward precision medicine.
Razzouk S
Clin Genet; 2014 Nov; 86(5):412-21. PubMed ID: 25143247
[TBL] [Abstract][Full Text] [Related]
13. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and chromosomal alterations in head and neck squamous cell carcinoma.
Bockmühl U; Petersen I
Virchows Arch; 2002 Dec; 441(6):541-50. PubMed ID: 12461610
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
16. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
17. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
[TBL] [Abstract][Full Text] [Related]
18. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
19. Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients.
Bérgamo NA; da Silva Veiga LC; dos Reis PP; Nishimoto IN; Magrin J; Kowalski LP; Squire JA; Rogatto SR
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):621-31. PubMed ID: 15701849
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
